Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma (RCC) and can target key driver mutations and induce antitumor immunity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback